English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90069/105176 (86%)
Visitors : 5720364      Online Users : 494
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/17976


    Title: Relationship between serum retinol-binding protein 4 and visfatin and the metabolic syndrome
    Authors: Lin), 林正介(Cheng-Chieh;(Lai, Ming-May);(Li, Tsai-Chung);(Li, Chia-Ing);(Liu, Chiu-Shong);(Chen, Ching-Chu);(Wu, Ming-Tsang)*
    Contributors: 健康產業管理學系
    Keywords: Retinol-binding protein 4;Visfatin;Metabolic syndrome;Insulin resistance
    Date: 2009-07
    Issue Date: 2012-11-26 12:06:08 (UTC+8)
    Abstract: Background
    This study investigates the relationship between serum concentration of RBP4 and visfatin and the metabolic syndrome.
    Methods
    Patients with metabolic syndrome were studied between October, 2004 and September, 2005. All study subjects were aged 40 and over and lived in Taichung city, Taiwan. The Third Report of the National Cholesterol Education Program's Adult Treatment Panel (ATP III, 2001) was used to define the metabolic syndrome. Serum RBP4 and visfatin levels were measured by enzyme-linked immunosorbent assay.

    Results
    Serum mean RBP4 levels in subjects who had all five abnormal components of metabolic syndrome (mean ± SD = 40.8 ± 18.6) and those who had all components except hyperglycemia (43.5 ± 23.5) were significantly higher than those in healthy controls (30.3 ± 14.0 μg/ml) (p < 0.05). Similar results were not found in serum visfatin levels. Using log-transformed serum RBP4 or visfatin levels as a dependent variable, we found that subjects with all five and four abnormal components of metabolic syndrome had significantly higher mean serum RBP4 levels (p = 0.043 and 0.034, respectively), compared to healthy controls, after adjusting for other covariates. In contrast, similar results were not found in serum visfatin levels.

    Conclusion
    Metabolic syndrome is significantly associated with serum RBP4, but not serum visfatin.
    Relation: DIABETES RESEARCH AND CLINICAL PRACTICE
    Appears in Collections:[健康產業管理學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML84View/Open
    1-s2.0-S0168822709001314-main.pdf183KbAdobe PDF124View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback